Literature DB >> 24577726

Protective effect of carvacrol on acute lung injury induced by lipopolysaccharide in mice.

Xiaosheng Feng1, Aiqing Jia.   

Abstract

Carvacrol, the major component of Plectranthus amboinicus, has been known to exhibit anti-inflammatory activities. The aim of this study was to investigate the effects of carvacrol on lipopolysaccharide (LPS)-induced endotoxemia and acute lung injury (ALI) in mice. Mice were injected intraperitoneally (i.p.) with LPS and the mortality of mice for 7 days were observed twice a day. Meanwhile, the protective effect of carvacrol (20, 40 or 80 mg/kg) on LPS-induced endotoxemia were detected. Using an experimental model of LPS-induced ALI, we examined the effect of carvacrol in resolving lung injury. The results showed that carvacrol could improve survival during lethal endotoxemia and attenuate LPS-induced ALI in mice. The anti-inflammatory mechanisms of carvacrol may be due to its ability to inhibit NF-κB and MAPKs signaling pathways, thereby inhibiting inflammatory cytokines TNF-α, IL-6 and IL-1β production.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24577726     DOI: 10.1007/s10753-014-9833-1

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  26 in total

Review 1.  Cytokine-mediated inflammation in acute lung injury.

Authors:  Richard B Goodman; Jérôme Pugin; Janet S Lee; Michael A Matthay
Journal:  Cytokine Growth Factor Rev       Date:  2003-12       Impact factor: 7.638

2.  Biomarkers of acute respiratory distress syndrome: Do good things lie nearby?

Authors:  Wolfgang M Kuebler
Journal:  Crit Care Med       Date:  2011-01       Impact factor: 7.598

3.  In vivo lipid-derived free radical formation by NADPH oxidase in acute lung injury induced by lipopolysaccharide: a model for ARDS.

Authors:  Keizo Sato; Maria B Kadiiska; Andrew J Ghio; Jean Corbett; Yang C Fann; Steven M Holland; Ronald G Thurman; Ronald P Mason
Journal:  FASEB J       Date:  2002-11       Impact factor: 5.191

Review 4.  Endotoxin and lung injury.

Authors:  K L Brigham; B Meyrick
Journal:  Am Rev Respir Dis       Date:  1986-05

5.  Protective effects of imipramine in murine endotoxin-induced acute lung injury.

Authors:  Jin Yang; Jie-ming Qu; Hanssa Summah; Jin Zhang; Ying-gang Zhu; Hong-ni Jiang
Journal:  Eur J Pharmacol       Date:  2010-04-18       Impact factor: 4.432

6.  Incidence and outcomes of acute lung injury.

Authors:  Gordon D Rubenfeld; Ellen Caldwell; Eve Peabody; Jim Weaver; Diane P Martin; Margaret Neff; Eric J Stern; Leonard D Hudson
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

7.  Berberine inhibits cytosolic phospholipase A2 and protects against LPS-induced lung injury and lethality independent of the alpha2-adrenergic receptor in mice.

Authors:  Hao-qing Zhang; Hua-dong Wang; Da-xiang Lu; Ren-bin Qi; Yan-ping Wang; Yu-xia Yan; Yong-mei Fu
Journal:  Shock       Date:  2008-05       Impact factor: 3.454

8.  Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung.

Authors:  Ida A J Giebelen; David J van Westerloo; Gregory J LaRosa; Alex F de Vos; Tom van der Poll
Journal:  Shock       Date:  2007-12       Impact factor: 3.454

9.  Kinetics of mitogen-activated protein kinase family in lipopolysaccharide-stimulated mouse Kupffer cells and their role in cytokine production.

Authors:  Jian-Xin Jiang; Yu Zhang; San-He Ji; Peifang Zhu; Zheng-Guo Wang
Journal:  Shock       Date:  2002-10       Impact factor: 3.454

10.  Ginsenosides compound K and Rh(2) inhibit tumor necrosis factor-alpha-induced activation of the NF-kappaB and JNK pathways in human astroglial cells.

Authors:  Kyungsun Choi; Myungsun Kim; Jeonghee Ryu; Chulhee Choi
Journal:  Neurosci Lett       Date:  2007-05-22       Impact factor: 3.046

View more
  8 in total

1.  Visfatin Exerts Immunotherapeutic Effects in Lipopolysaccharide-Induced Acute Lung Injury in Murine Model.

Authors:  You Luo; Xin-Xin Pang; Abdur Rahman Ansari; Xin-Tong Wu; Hui-Zhen Li; Zhe-Wei Zhang; Hui Song
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

2.  Supplemental carvacrol can reduce the severity of inflammation by influencing the production of mediators of inflammation.

Authors:  Mehmet Kara; Sema Uslu; Fatih Demirci; Halide Edip Temel; Canan Baydemir
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

3.  Effects of Carvacrol on Survival, Mesenteric Blood Flow, Aortic Function and Multiple Organ Injury in a Murine Model of Polymicrobial Sepsis.

Authors:  Erdem Kamil Ozer; Mustafa Tugrul Goktas; Aysun Toker; Hulagu Bariskaner; Ceyhan Ugurluoglu; Alper Bektas Iskit
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

4.  Carvacrol ameliorates acute campylobacteriosis in a clinical murine infection model.

Authors:  Stefan Bereswill; Markus M Heimesaat; Soraya Mousavi; Anna-Maria Schmidt; Ulrike Escher; Sophie Kittler; Corinna Kehrenberg; Elisa Thunhorst
Journal:  Gut Pathog       Date:  2020-01-08       Impact factor: 4.181

5.  Core genes involved in the regulation of acute lung injury and their association with COVID-19 and tumor progression: A bioinformatics and experimental study.

Authors:  Aleksandra V Sen'kova; Innokenty A Savin; Evgenyi V Brenner; Marina A Zenkova; Andrey V Markov
Journal:  PLoS One       Date:  2021-11-22       Impact factor: 3.240

6.  The effect of carvacrol on respiratory syncytial virus infection in mice model: caution in the use of herbal medicines.

Authors:  Marzieh Faraji-Zonouz; Farshad Khodakhah; Forough Tavakoli; Alireza Tahamtan; Masoumeh Tavakoli-Yaraki; Farhad Rezaie; Talat Mokhatri-Azad; Vahid Salimi
Journal:  Iran J Microbiol       Date:  2021-10

Review 7.  Therapeutic Potential of Medicinal Plants and Their Constituents on Lung Inflammatory Disorders.

Authors:  Hyun Pyo Kim; Hyun Lim; Yong Soo Kwon
Journal:  Biomol Ther (Seoul)       Date:  2017-03-01       Impact factor: 4.634

8.  Dual Effect of Soloxolone Methyl on LPS-Induced Inflammation In Vitro and In Vivo.

Authors:  Andrey V Markov; Aleksandra V Sen'kova; Valeriya O Babich; Kirill V Odarenko; Vadim A Talyshev; Oksana V Salomatina; Nariman F Salakhutdinov; Marina A Zenkova; Evgeniya B Logashenko
Journal:  Int J Mol Sci       Date:  2020-10-23       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.